St. Louis University
Also known as: Cardinal Glennon Children's Hospital | Catherine Cibulskis, MD | Centre for Therapeutic Innovations in Oncology and Haematology / Saint Louis University Hospital | Saint Louis University | Saint Louis University Cardinal Glennon Children's Hospital | Saint Louis University Center for Vaccine Development, St. Louis, MO USA | Saint Louis University, Department of Internal Medicine, Division of Hematology and Oncology | Saint Louis University, Dept. of Internal Medicine, Div. of Hematology and Oncology | Saint Louis University Dermatology | Saint Louis University Hospital | Saint-Louis University, Saint-Louis, USA | Saint Louis University School of Medicine | Saint Louis University School of Medicine Department of Neurology and Psychiatry | Sandeep Singh Dhindsa, M.D., F.A.C.E | SSM Cardinal Glennon Children's Medical Center | St. Louis University | St. Louis University Dermatology | St. Louis University Hospital | St. Louis University Medical Center | St. Louis University School of Medicine | Tarek M. El-Achkar
Highest phase reached
Phase 4
Timeline
1810s
- Jan 1, 1818
St. Louis University— Founded
2010s
- May 30, 2013
allogeneic hematopoietic stem cells— NDA Secondary Org
Drugs by trial phase (113 distinct, 78 trials)
Phase 4 (22 own, 0 via acquisition)
Phase 3 (26 own, 0 via acquisition)
Phase 2 (29 own, 0 via acquisition)
Phase 1 (20 own, 0 via acquisition)
Other trials (16 own, 0 via acquisition)
Indications
Studied for
- Abscess
- Alzheimer Disease
- Anemia, Sickle Cell
- Asthma
- Basal Cell Carcinoma
- Birth Weight
- Body Weight
- Bone Neoplasms
- Brain Diseases
- Brain Ischemia
- Breast Neoplasms
- Carcinoma
- Carcinoma, Renal Cell
- Cardiomyopathies
- Cardiomyopathy, Dilated
- Cardiovascular Diseases
- Central Nervous System Neoplasms
- Charcot-Marie-Tooth Disease
- Cholestasis
- Chorioamnionitis
- Communicable Diseases
- Coronary Artery Disease
- Coronary Disease
- Cystic Fibrosis
- Dementia
- Diabetes Mellitus
- Diabetes Mellitus, Type 2
- Digestive System Diseases
- Dyspepsia
- Endometritis
- Fatigue
- Fatty Liver
- Fibrosis
- Fistula
- Gastrointestinal Diseases
- Giant Cell Tumor of Bone
- Giant Cell Tumors
- Heart Diseases
- Heart Failure
- Hepatitis
- Hepatitis A
- Hepatitis C
- Hepatitis C, Chronic
- Hereditary Sensory and Motor Neuropathy
- HIV Infections
- Hyperemia
- Hypertension
- Hypogonadism
- Hypoxia
- Hypoxia-Ischemia, Brain
- Infarction
- Infections
- Inflammation
- Influenza, Human
- Insulin Resistance
- Ischemia
- Liver Cirrhosis
- Liver Cirrhosis, Biliary
- Melanoma
- Mucopolysaccharidoses
- Mucopolysaccharidosis II
- Multiple Myeloma
- Multiple Sclerosis
- Myocardial Infarction
- Myocardial Ischemia
- Neoplasm Metastasis
- Neoplasms
- Nerve Compression Syndromes
- Nervous System Neoplasms
- Neuroblastoma
- Non-alcoholic Fatty Liver Disease
- Overweight
- Pancreatic Diseases
- Pneumonia
- Postoperative Pain
- Recurrence
- Renal Insufficiency
- Sclerosis
- Skin Diseases
- Skin Diseases, Infectious
- Sleep Apnea, Obstructive
- Sleep Apnea Syndromes
- Sleepiness
- Syndrome
- Thrombosis
- Tooth Diseases
- Tuberculosis
- Virus Diseases
- Vomiting
Marketed drugs (1)
Recent trials (50)
- NCT07158476Sponsor investigatorPhase 4Oct 21, 2025
- NCT07158476Lead sponsorPhase 4Oct 21, 2025
- NCT07158476OfficialPhase 4Oct 21, 2025
- NCT07063849Sponsor investigatorPhase 1May 20, 2025
- NCT07063849Lead sponsorPhase 1May 20, 2025
- NCT07024940OfficialN/AApr 25, 2025
- NCT07024940Sponsor investigatorN/AApr 25, 2025
- NCT07024940Lead sponsorN/AApr 25, 2025
- NCT06055712Reponsible party - principal investigatorPhase 4Sep 11, 2023
- NCT06055712Lead sponsorPhase 4Sep 11, 2023
- NCT06055712Overall official - principal investigatorPhase 4Sep 11, 2023
- NCT05919888Overall official - principal investigatorPhase 4Jun 26, 2023
- NCT05919888Reponsible party - principal investigatorPhase 4Jun 26, 2023
- NCT05919888Lead sponsorPhase 4Jun 26, 2023
- NCT05919888OfficialPhase 4Jun 26, 2023
Details
- Founded
- St. Louis, MO, US Jan 1, 1818
- Last known activity
- Oct 21, 2025